Diabetic Foot Ulcer Treatment Market to Grow with a CAGR of 7.45% through 2030
The increasing prevalence of diabetes is expected to
drive the growth of Global Diabetic Foot Ulcer Treatment Market in the forecast
period, 2026-2030.
According to TechSci Research report, “Global
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2030”, Global Diabetic Foot Ulcer
Treatment Market was valued at USD 5.51 billion in 2024 and is expected to
reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. This can
be ascribed to the growing prevalence of diabetes and obesity types of chronic
diseases among the aging population across the globe. Additionally, the growing
geriatric population can spread different chronic diseases such as diabetes,
and obesity along with advancing age, leading sedentary lifestyle and longer
duration of diabetes mellitus can demand multiple treatment options by patients
diagnosed especially in the developed countries in North America and Europe is
expected to create lucrative opportunities for the market growth in coming
years. Similarly, crowing technological advancements in treatment options
in emerging countries will further boost market growth during the forecast
period. Also, the availability of explicit dressings for a specific type of
diabetic is expected to drive market growth during the forecast period.
However, high cost of the advanced wound care devices along
with lack of reimbursement procedure for the treatment of diabetic foot ulcers
in the developing countries slowing down the growth of global diabetic
foot ulcer treatment market in the forecast period. Similarly, high risks
and complications associated with treatments may hamper the diabetic foot
ulcer treatment market growth during the forecast period. Also, lack of
awareness regarding the advanced treatment in emerging countries can further
restrict the growth of global diabetic foot ulcer treatment market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Diabetic Foot Ulcer Treatment Market"
The global diabetic foot ulcer treatment market
is segmented into treatment, ulcer treatment, end user, regional distribution
and company.
Based on Treatment, the Biologics category is witnessing the
fastest growth among all treatment types. This surge is primarily driven by the
increasing demand for advanced therapies that go beyond symptom management and
aim to accelerate wound healing at a cellular and molecular level. Biologics,
such as growth factors, skin substitutes, stem cell therapies, and
extracellular matrix-based products, are becoming increasingly favored in
treating chronic and non-healing diabetic foot ulcers. These products stimulate
the body's natural healing mechanisms, promote angiogenesis, and help rebuild
damaged tissue, offering significantly better outcomes in severe or
non-responsive DFU cases compared to conventional dressings or
antibiotics. The rising incidence of treatment-resistant ulcers, along
with the growing availability of FDA- and EMA-approved biologic therapies, has
also spurred adoption in both developed and emerging markets. For instance,
epidermal growth factors (EGFs) and placental-derived products are gaining
clinical acceptance due to their proven efficacy in reducing healing time and
minimizing the risk of amputation. Government support and regulatory pathways
are further encouraging the development and usage of biologics. For example,
programs such as the U.S. Biomedical Advanced Research and Development
Authority (BARDA) have invested in advanced wound healing solutions,
particularly those applicable to diabetic and burn patients.
Based on the Region, the Asia Pacific region is witnessing
the fastest growth in the global diabetic foot ulcer (DFU) treatment market.
This growth is being driven by a combination of rising diabetes prevalence,
increasing healthcare investments, and improved access to advanced wound care
technologies. Countries such as India, China, Indonesia, and the Philippines
are experiencing a significant surge in diabetic populations due to lifestyle
changes, aging demographics, and urbanization. According to the International
Diabetes Federation (IDF), the Asia Pacific region is home to over 60% of the
global diabetic population, with India and China alone accounting for nearly
one-third. As diabetes cases grow, so does the incidence of related
complications, including foot ulcers, infections, and amputations, which are
often preventable with timely and effective care. Governments in the
region are increasingly recognizing the burden of chronic diseases and are
launching national diabetes management programs, improving primary care access,
and supporting early screening initiatives. For example, India’s National
Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular
Diseases and Stroke (NPCDCS) is a significant step toward addressing diabetes
complications through community-level interventions. Additionally, rising
medical tourism, growing awareness among patients, and the expansion of private
healthcare facilities are accelerating the adoption of specialized wound care
solutions and advanced dressings. Multinational companies are also entering the
Asia Pacific market through partnerships and local manufacturing, making
treatment more affordable and accessible.
Major companies operating in the Global Diabetic Foot
Ulcer Treatment Market are:
- 3M
Company
- Medtronic
Plc
- ConvaTec,
Inc.
- Coloplast
Corporation
- Smith
& Nephew Plc
- B
Braun Melsungen AG
- Medline
Industries, Inc.
- Organogenesis,
Inc.
- Molnlycke
Health Care AB
- Acelity
L.P., Inc.
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“North America was expected to dominate in The Global Diabetic
Foot Ulcer Treatment Market on account due to the increasing prevalence of
diabetic foot ulcers among the population across the region. Similarly,
launched of a new medicine help manufacturers to reap good returns in the
market which will further propel the market growth over the years. Furthermore,
increasing advanced technology along with developing healthcare expenditure for
the treatment of different types of ulcers are further contributing to the
demand for diabetic foot ulcer treatment. Besides, the availability of skilled
professionals, growing awareness about a new treatment for a diabetic foot
ulcer, rapid urbanization, and modernization boosted the lifestyle practices of
the people which has given rise to a number of chronic diseases and growing
investment by government organizations in the healthcare sector in the region
is further expected to create lucrative opportunities for the market growth”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
global management consulting firm.
“Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of global diabetic foot ulcer
treatment market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global diabetic foot
ulcer treatment market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com